Le Lézard
Classified in: Health

Information Update - Health Canada evaluating NDMA in metformin drugs


OTTAWA, Dec. 5, 2019 /CNW/ - Health Canada is aware that some metformin products available outside Canada have been found to contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above the acceptable limit. Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes.

At this time, Health Canada is not aware of any metformin products in Canada containing NDMA above acceptable levels. The Department has asked companies to test their metformin products and is collecting samples from companies to conduct its own testing. Health Canada is also working closely with international regulatory partners to inform its assessment of the issue and to determine whether any metformin product in Canada is affected. If a risk to Canadians is identified, the Department will take action as needed and inform Canadians. 

Patients should not stop taking their metformin drug without first discussing options with their health care provider. While Health Canada is not aware of any affected products in Canada at this time, it is important to note that the risks from not having adequate diabetes treatment far outweigh any possible effects of exposure to the levels of NDMA found in metformin in other countries. Stopping metformin medication could lead to uncontrolled diabetes, which has serious health risks:

NDMA is classified as a probable human carcinogen. We are all exposed to low levels of nitrosamines through a variety of foods (such as smoked and cured meats, dairy products and vegetables), drinking water and air pollution. NDMA is not expected to cause harm when ingested at low levels. A person taking a drug that contains NDMA at or below the acceptable level every day for 70 years is not expected to have an increased risk of cancer.

Health Canada has been working to address the issue of NDMA and other nitrosamine impurities found in certain medications since the summer of 2018. The Department continues to work closely with international regulatory partners to understand the root causes and to address them.

Related links:

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 08:38
Since 2019, Star Body has been rocking the world of skin and sun care with their one of a kind Espress-O-Yourself line of caffeine-infused products. Though caffeine is often used in high-end beauty products, applying coffee extract to their already...

at 08:38
Viewgol, a national leader in data and analytics technology and services with deep expertise in healthcare revenue cycle management (RCM), announced today the appointment of Reid Storch as Chief Revenue Officer.  Mr. Storch's appointment comes as...

at 08:37
Medi-Weightloss Noblesville/Fishers celebrated one year changing lives on July 31, 2020. Since opening in Noblesville, Medi-Weightloss has helped patients achieve their goal weight and lose over 2,600 pounds. Known as The One That Works!, the...

at 08:37
The Board of Directors of HealthSignals, LLC is delighted to announce the appointment of its newest Board Member, Sheriff Popoola, who officially joined the board on May 20, 2020. Sheriff joined HealthSignals in 2013 as its Executive VP for...

at 08:35
Ligand Pharmaceuticals Incorporated announces CStone Pharmaceuticals ("CStone", HKEX: 2616) recently reported that its OmniAb-derived anti-PD-L1 mAb CS1001 combined with platinum-based chemotherapy met its pre-specified primary endpoint, as assessed...

at 08:35
Technavio has been monitoring the fermentation chemicals market and it is poised to grow by $ 26.38 bn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report offers an up-to-date analysis regarding the current market...



News published on 5 december 2019 at 21:00 and distributed by: